BOMBELLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 9.644
EU - Europa 4.369
AS - Asia 1.253
SA - Sud America 20
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 15.325
Nazione #
US - Stati Uniti d'America 9.489
DE - Germania 923
IT - Italia 882
SE - Svezia 762
CN - Cina 711
IE - Irlanda 700
UA - Ucraina 398
HK - Hong Kong 280
GB - Regno Unito 227
CA - Canada 149
RU - Federazione Russa 128
FI - Finlandia 123
VN - Vietnam 83
IN - India 65
FR - Francia 64
DK - Danimarca 48
NL - Olanda 32
AT - Austria 26
TR - Turchia 26
SG - Singapore 24
BE - Belgio 15
IR - Iran 15
RO - Romania 14
EU - Europa 11
BR - Brasile 10
JP - Giappone 10
ID - Indonesia 8
AU - Australia 7
KR - Corea 7
CH - Svizzera 6
PE - Perù 5
MY - Malesia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
BJ - Benin 3
ES - Italia 3
LK - Sri Lanka 3
PL - Polonia 3
PT - Portogallo 3
RS - Serbia 3
BB - Barbados 2
CM - Camerun 2
CZ - Repubblica Ceca 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
MG - Madagascar 2
MX - Messico 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MU - Mauritius 1
NP - Nepal 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 15.325
Città #
Ann Arbor 1.953
Woodbridge 944
Fairfield 824
Houston 758
Chandler 708
Dublin 664
Frankfurt am Main 660
Wilmington 485
Jacksonville 464
Ashburn 448
Dearborn 435
Seattle 360
New York 352
Hong Kong 276
Cambridge 268
Milan 255
Princeton 244
Nanjing 129
Altamura 122
Lawrence 117
Beijing 103
Shanghai 88
Lachine 79
San Diego 76
Nanchang 52
Andover 43
Guangzhou 39
Dong Ket 38
Fremont 38
Hebei 36
Helsinki 35
Shenyang 33
Falls Church 31
Lissone 31
Toronto 30
Tianjin 28
Vienna 25
Jiaxing 22
Boardman 20
Nürnberg 20
Ottawa 20
Jinan 19
Kunming 19
London 19
Ningbo 19
Los Angeles 18
Norwalk 18
Changsha 17
Monza 16
Lentate sul Seveso 14
Rome 14
Hangzhou 13
Huizen 13
Brussels 12
Philadelphia 12
Zhengzhou 12
Cinisello Balsamo 11
Mountain View 11
Pune 11
Redmond 11
Auburn Hills 9
Bergamo 9
Sacramento 9
Washington 9
Edmonton 8
Hefei 8
Padova 8
Sesto San Giovanni 8
Bonndorf 7
Genoa 7
New Delhi 7
Turin 7
Desio 6
Detroit 6
Lanzhou 6
Lappeenranta 6
Leawood 6
Phoenix 6
San Mateo 6
Taizhou 6
University Park 6
Busto Arsizio 5
Carate Brianza 5
Chicago 5
Cologno Monzese 5
Fuzhou 5
Hyderabad 5
Lima 5
Mcallen 5
Montréal 5
Moscow 5
Pioltello 5
Saint Petersburg 5
San Giuliano 5
Taiyuan 5
Amsterdam 4
Bologna 4
Bucharest 4
Changchun 4
Garbagnate Milanese 4
Totale 11.872
Nome #
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 279
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 221
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 217
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 193
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 190
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 182
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 182
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 180
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 179
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 179
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 175
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 174
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 174
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 173
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 170
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 170
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 169
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 167
The Pamela study: main findings and perspectives 164
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 160
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 159
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 159
The association between 24-h blood pressure patterns and left ventricular mechanics 159
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 158
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 158
Combined effects of hypertension and hypercholesterolemia on radial artery function 155
Differing associations for sport versus occupational physical activity and cardiovascular risk 155
Role of ambulatory blood pressure monitoring in resistant hypertension 153
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 150
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 150
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 149
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 145
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 142
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 142
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 141
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 141
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 140
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 139
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 138
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 138
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 136
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 136
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 135
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 134
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 133
Should white-coat hypertension in diabetes be treated? Pro 132
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 132
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 130
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 130
HIV and metabolic syndrome - A comparison with the general population 129
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 128
Do reverse dippers have the highest risk of right ventricular remodeling? 128
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 127
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 126
The Pamela Study: Old and New Findings 124
Diurnal blood pressure variation and sympathetic activity 123
Diagnosis and management of patients with white-coat and masked hypertension 120
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 120
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 120
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 120
New-onset left atrial enlargement in a general population 120
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 120
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 119
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 115
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 115
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 115
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 114
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 114
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 113
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 112
Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population 111
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 111
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 110
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 109
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial) 108
Long-term changes in left ventricular mass echocardiographic findings from a general population 108
Long-term risk of sustained hypertension in white-coat or masked hypertension 107
Ambulatory blood pressure in air traffic controllers 107
Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population? 107
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 107
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 106
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 105
Predictive value of different indices of blood pressure variability on 104
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 104
Seasonal variations in home and ambulatory blood pressure in the PAMELA population 102
Right heart remodeling induced by arterial hypertension: Could strain assessment be helpful? 102
The importance of pulse pressure on cardiovascular risk and total mortality in the general population: Is sex relevant? 102
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 102
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 101
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 100
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 100
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 97
Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension 97
Hypertensive heart disease beyond left ventricular hypertrophy: Are we ready for echocardiographic strain evaluation in everyday clinical practice? 96
Arterial compliance in familial hypercholesterolaemia: A preliminary report 93
Uric acid and risk of new-onsetmetabolic syndrome, impaired fasting glucose and diabetesmellitus in a general Italian population: data from the Pressioni ArterioseMonitorate E Loro Associazioni study 93
Adverse prognostic value of persistent office blood pressure elevation in White coat Hypertension 92
Cardiovascular Risk Associated With White Coat Hypertension: Pro Side of the Argument. 90
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 89
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 89
Totale 13.438
Categoria #
all - tutte 50.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019521 0 0 0 0 0 0 0 0 0 0 223 298
2019/20202.820 325 128 202 220 283 385 403 210 259 172 165 68
2020/20212.352 141 119 225 254 202 203 219 225 185 262 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.079 62 71 104 123 298 598 457 91 232 43 0 0
Totale 15.926